Inactive Instrument

Other languages Calmare Therapeutics Incorporated

Equities

CTTC

US13126R1023

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

CALMARE THERAPEUTICS INC : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	20-06-09
Calmare Therapeutics Incorporated Wins $2.5 Million Federal Supply Schedule Contract	20-06-09
Calmare Therapeutics Incorporated Announces Board Changes	19-07-19
Carl O'connell to Resign as Member of the Board of Directors of Calmare Therapeutics Incorporation, Effective on or About June 26, 2019	19-06-12
Declaration of Voting Results by Calmare Therapeutics	18-07-02
Calmare Therapeutics Declares Preliminary Tally of Consents by Shareholders	18-06-15
Calmare Therapeutics Solicits Proxies from Shareholders	18-01-16
Calmare Therapeutics Solicits Proxies from Shareholders	18-01-12
Calmare Therapeutics Solicits Proxies from Shareholders	18-01-02
Stanley Yarbro Solicits Proxies from Shareholders of Calmare Therapeutics	17-12-08
Stanley Yarbro Solicits Proxies from Shareholders of Calmare Therapeutics	17-12-04
Stanley Yarbro Solicits Proxies from Shareholders of Calmare Therapeutics	17-11-22
Stanley Yarbro Sends Letter to Board of Directors of Calmare Therapeutics	17-09-21
Stanley Yarbro Sends Director Nomination Notice to Calmare Therapeutics	17-09-21
Stanley Yarbro Threatens Calmare Therapeutics with Legal Action	17-09-21
Calmare Therapeutics Incorporated Auditor Raises 'Going Concern' Doubt	17-07-20
Stanley Yarbro Sends Letter to Calmare Therapeutics	17-06-30
Calmare Therapeutics, Inc. Removes Stan Yarbro as Director	17-03-23
Calmare Therapeutics Incorporated Resignation of Robert T. Conway and Steve Roehrich from the Board	17-02-23
Calmare Therapeutics Incorporated cancelled the transaction announced on September 10, 2013	16-09-09

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Calmare Therapeutics Incorporated

Equities

CTTC

US13126R1023

Other languages

Filters